XClose

UCL News

Home
Menu

Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant

4 June 2021

Levels of antibodies in vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are, on average, lower than those against variants previously circulating in the UK, finds a new study involving UCL scientists.

Read: Financial Times (£), More: Evening Standard, UCL News